5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis
    Journal Article

    Han, H.; Wang, Y.; Curto, J.; Gurrapu, S.; Laudato, S.; Rumandla, A.; Chakraborty, G.; Wang, X.; Chen, H.; Jiang, Y.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Health-related quality of life of patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin after platinum and PD-1/PD-L1 inhibitor therapy: Results from cohort 1 of the phase 2 EV-201 clinical trial
    Journal Article

    McGregor, B.; O'Donnell, P. H.; Balar, A.; Petrylak, D.; Rosenberg, J.; Yu, E. Y.; Quinn, D. I.; Heath, E. I.; Campbell, M.; Hepp, Z.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy
    Journal Article

    Almassi, N.; Vertosick, E. A.; Sjoberg, D. D.; Wong, N. C.; Huang, C.; Pietzak, E. J.; Cha, E. K.; Donahue, T. F.; Dalbagni, G.; Bochner, B. H.; more...
    BJU International (2022)

    Fulltext@MSK | Save
  • Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)
    Journal Article

    Tilburt, J. C.; Zahrieh, D.; Pacyna, J. E.; Petereit, D. G.; Kaur, J. S.; Rapkin, B. D.; Grubb, R. L.; Chang, G. J. 3rd; Morris, M. J.; Kovac, E. Z.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Management of dermatologic events associated with the Nectin-4-directed antibody-drug conjugate enfortumab vedotin
    Journal Article

    Lacouture, M. E.; Patel, A. B.; Rosenberg, J. E.; O'Donnell, P. H.
    The Oncologist (2022)

    Fulltext@MSK | Save
  • The Prescription Drug User Fee Act: Much more than user fees
    Journal Article

    Mitchell, A. P.; Trivedi, N. U.; Bach, P. B.
    Medical Care (2022)

    Fulltext@MSK | Save
  • Real-world use of bone-modifying agents in metastatic castration-sensitive prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Bach, P. B.; Morris, M. J.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor
    Journal Article

    Chi, P.; Qin, L. X.; Nguyen, B.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Biomarker analysis from CheckMate 214: Nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma
    Journal Article

    Motzer, R. J.; Choueiri, T. K.; McDermott, D. F.; Powles, T.; Vano, Y. A.; Gupta, S.; Yao, J.; Han, C.; Ammar, R.; Papillon-Cavanagh, S.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save